These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3281060)

  • 21. [Alizapride in the treatment of vomiting induced by cytostatic agents].
    Bierbaum HG
    Fortschr Med; 1983 Apr; 101(14):662-4. PubMed ID: 6852737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alizapride versus placebo in premedication for esophagogastroduodenoscopy. Double-blind clinical study. Experimental research in vitro].
    Cosentino F; Prato A; Laudani A; Percolla S; Franco S; Veroux PF; Immè A
    Minerva Dietol Gastroenterol; 1989; 35(1):35-7. PubMed ID: 2725928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose alizapride versus high-dose domperidone: a double-blind comparative study in the management of cis-platinum-induced emesis.
    Huys J; Troch M; Bourguignon RP; Smets P
    Curr Med Res Opin; 1985; 9(6):400-6. PubMed ID: 3886305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
    Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
    Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiemetic and antinauseant effect of alizapride in patients subjected to antiblastic infusion chemotherapy in a day-hospital regime].
    Cicchetti F; Viganò P; Borghi CM; Franzini A; Alfano G; Antolini C
    G Ital Oncol; 1989; 9(1):18-21. PubMed ID: 2707835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of vomiting in infants and children induced by acute infectious pathology. A comparative study of alizapride versus metopimazine].
    Debray H; Guihard J; Peyramond D; Tron P
    Ann Pediatr (Paris); 1990 Dec; 37(10):683-7. PubMed ID: 2291597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antiblastic agent-induced vomiting: possibilities of its prevention and alizapride therapy].
    Petrella V; Cantone PA; Alciato P; Gagliardini R; Fico D
    Minerva Med; 1989 Apr; 80(4):389-92. PubMed ID: 2725942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of anti-emetics after intragastric balloon placement: experience with three different drug treatments.
    Van Hee R; Van Wiemeersch S; Lasters B; Weyler J
    Obes Surg; 2003 Dec; 13(6):932-7. PubMed ID: 14738685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Randomized study of the antiemetic efficacy of alizapride versus alizapride + dexamethasone].
    Epifani C; Scognamiglio G; Prete C; Alberio F; Gini G; Valli M
    G Ital Oncol; 1990; 10(4):115-9. PubMed ID: 2093079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial.
    Bleiberg H; Gerard B; Dalesio O; Crespeigne N; Rozencweig M
    Cancer Chemother Pharmacol; 1988; 22(4):316-20. PubMed ID: 3048762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alizapride, a new substituted benzamide, as an antiemetic during cancer chemotherapy.
    Joss RA; Galeazzi RL; Bischoff AK; Brunner KW
    Eur J Clin Pharmacol; 1985; 27(6):721-5. PubMed ID: 3987777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind randomized controlled trial of ginger for the prevention of postoperative nausea and vomiting.
    Arfeen Z; Owen H; Plummer JL; Ilsley AH; Sorby-Adams RA; Doecke CJ
    Anaesth Intensive Care; 1995 Aug; 23(4):449-52. PubMed ID: 7485935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The value of alizapride in the treatment of vomiting in infants and children].
    Kassi M
    Ann Pediatr (Paris); 1990 Feb; 37(2):131-4. PubMed ID: 2321904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation sickness--a new approach to management.
    McNab D
    Radiography; 1978 Oct; 44(526):239-40. PubMed ID: 364527
    [No Abstract]   [Full Text] [Related]  

  • 35. Tropisetron (Navoban) compared with alizapride in the control of emesis induced by cyclophosphamide-containing regimens.
    De Nigris A; Paladini G; Giosa F; Sfeir C; Pagan MG; Maltoni C
    Eur J Cancer; 1994; 30A(12):1902-3. PubMed ID: 7880624
    [No Abstract]   [Full Text] [Related]  

  • 36. [Postoperative vomiting: drug prevention and therapy with established agents in the child].
    Kretz FJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Oct; 32(10):620-2. PubMed ID: 9445559
    [No Abstract]   [Full Text] [Related]  

  • 37. Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy.
    Niederle N; Schütte J; Schmidt CG
    Klin Wochenschr; 1986 Apr; 64(8):362-5. PubMed ID: 3009962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiemetic efficacy of escalating doses of alizapride against chemotherapy-induced emesis.
    Abad-Esteve A; Rosell R; Moreno I; Serichol M; Moya L; Ribas-Mundo M
    Oncology; 1989; 46(4):235-7. PubMed ID: 2740066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of domperidone and metoclopramide as antiemetics in day care abortion patients.
    Waldmann CS; Verghese C; Short SM; Goldhill DR; Evans SJ
    Br J Clin Pharmacol; 1985 Mar; 19(3):307-10. PubMed ID: 3885984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of intravenously administered alizapride and prochlorperazine in cisplatin-induced emesis.
    Roché H; Hyman G; Nahas G; Stoopler M; Ellison R; Desjardins R
    Cancer Invest; 1987; 5(2):89-93. PubMed ID: 3607576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.